Skip to content
DraconiticResearch
Search Sources API
226,742 studies31 sourcesUpdated 52 min ago
Peer-reviewedCC BY-NC-ND 4.0Inflammation

Microbiome-derived Metabolites in Anti-inflammatory Therapy: from Mechanisms to Translational Potential

6 affiliations
  1. 1Department of Microbiology, Gauhati Medical College and Hospital, Guwahati, Assam India
  2. 2Department of Anatomy, Barpeta Medical College and Hospital, Barpeta, Assam India
  3. 3Department of Urology and Renal Transplant, Gauhati Medical College and Hospital, Guwahati, India
  4. 4Faculty of Allied and Healthcare Sciences, Assam Down Town University, Sankar Madhab Path, Gandhi Nagar, Panikhaiti, Guwahati, Pin-781026 Assam India
  5. 5GNA School of Pharmacy, GNA University, Phagwara, Punjab India
  6. 6Symbiosis Medical College for Women & Symbiosis University Hospital and Research Centre, Symbiosis International (Deemed University), Pune, 412115 India

Abstract

Chronic inflammation underlies autoimmune, metabolic, cardiovascular, and neurodegenerative disorders and remains difficult to manage because current anti-inflammatory therapies often have systemic adverse effects and variable clinical efficacy. This review synthesizes evidence on microbiome-associated metabolites relevant to inflammation, including short-chain fatty acids, microbial indole derivatives, secondary bile acids, polyamines, trimethylamine N-oxide, and selected host-microbe co-metabolites. These compounds regulate host immunity through G-protein-coupled receptors, nuclear receptors, epigenetic mechanisms, inflammasome regulation, and major inflammatory signaling pathways such as NF-kappaB, MAPK, and JAK-STAT. The translational potential of direct metabolite administration, prodrug design, microbiome engineering, dietary modulation, and targeted delivery systems is discussed alongside key limitations, including low bioavailability, context-dependent activity, interindividual microbiome variation, incomplete pharmacokinetic data, and the limited number of well-controlled human trials. Overall, microbiome-associated metabolites represent promising but still evolving therapeutic candidates; their clinical use requires stronger causal evidence, standardized formulations, safety evaluation, and disease-specific validation.

Graphical Abstract: Microbiome-associated metabolites, including short-chain fatty acids, microbial indole derivatives, secondary bile acids, and polyamines, contribute to epithelial homeostasis and regulate immune signaling through pathways such as NF-kappaB, MAPK, JAK-STAT, inflammasome activation, GPCR signaling, and epigenetic remodeling. Therapeutic strategies such as metabolite supplementation, prodrug design, microbiome engineering, and nano-delivery systems may enable targeted anti-inflammatory effects, but their clinical application remains dependent on stronger human evidence and standardized delivery approaches.

Related

  1. Microbial-derived metabolites in cancer: evidence boundaries, immune mechanisms and translational pathways
    Xuefeng Shi, Shunjun Wang, Wenhao Ouyang
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0Full textMolecular biology & gene regulationPMCCrossrefEurope PMC
  2. Epigenetic regulation of immune checkpoint signaling by microbial metabolites: mechanisms, therapeutic potential, and future perspectives
    Asiya Nazir, Rafia Nazir, Sarika Sharma +2
    Frontiers in immunologyPeer-reviewedCC BYFull textMolecular biology & gene regulationEurope PMCCrossref
  3. Gut microbiota- and probiotic-derived bioactive metabolites: mechanisms, evidence, and therapeutic potential in metabolic disorders
    Oghenerobor B. Akpor, Ayotunde O. Ajinde
    Frontiers in Cellular and Infection MicrobiologyPeer-reviewedCC BY 4.0Full textMolecular biology & gene regulationPMCEurope PMC
  4. Herbal Therapeutics in Osteoporosis: Mechanisms, Evidence, and Translational Potential
    Elnaz Vafadar Moradi, Sina Vossoughinia, Zahra Yazdanpanah +3
    Phytotherapy ResearchPeer-reviewedCC BY-NC-ND 4.0Full textMolecular biology & gene regulationPMC
  5. Exercise-Associated Gut Microbiota Remodeling and Cardiovascular Protection: Potential Mechanisms Involving Inflammatory Regulation
    Xinxin Liu, Dandan Jing, Xuan Liu +2
    MetabolitesPeer-reviewedCC BY 4.0Full textMolecular biology & gene regulationCrossrefEurope PMC
BibTeX
@article{sarma2026microbiomederived,
  title = {{Microbiome-derived Metabolites in Anti-inflammatory Therapy: from Mechanisms to Translational Potential}},
  author = {Vaishali Sarma and Santanu Kumar Sarma and Debanga Sarma and Moitrayee Devi and Dinesh Kumar and Neeraj Choudhary and Suresh Babu Kondaveeti and Arnabjyoti Deva Sarma},
  journal = {Inflammation},
  year = {2026},
  month = aug,
  doi = {10.1007/s10753-026-02574-8},
  url = {https://doi.org/10.1007/s10753-026-02574-8},
  note = {CC BY-NC-ND 4.0},
}
RIS
TY  - JOUR
TI  - Microbiome-derived Metabolites in Anti-inflammatory Therapy: from Mechanisms to Translational Potential
AU  - Vaishali Sarma
AU  - Santanu Kumar Sarma
AU  - Debanga Sarma
AU  - Moitrayee Devi
AU  - Dinesh Kumar
AU  - Neeraj Choudhary
AU  - Suresh Babu Kondaveeti
AU  - Arnabjyoti Deva Sarma
PY  - 2026
DA  - 2026/08/14
JO  - Inflammation
DO  - 10.1007/s10753-026-02574-8
UR  - https://doi.org/10.1007/s10753-026-02574-8
AB  - Chronic inflammation underlies autoimmune, metabolic, cardiovascular, and neurodegenerative disorders and remains difficult to manage because current anti-inflammatory therapies often have systemic adverse effects and variable clinical efficacy. This review synthesizes evidence on microbiome-associated metabolites relevant to inflammation, including short-chain fatty acids, microbial indole derivatives, secondary bile acids, polyamines, trimethylamine N-oxide, and selected host-microbe co-metabolites. These compounds regulate host immunity through G-protein-coupled receptors, nuclear receptors, epigenetic mechanisms, inflammasome regulation, and major inflammatory signaling pathways such as NF-kappaB, MAPK, and JAK-STAT. The translational potential of direct metabolite administration, prodrug design, microbiome engineering, dietary modulation, and targeted delivery systems is discussed alongside key limitations, including low bioavailability, context-dependent activity, interindividual microbiome variation, incomplete pharmacokinetic data, and the limited number of well-controlled human trials. Overall, microbiome-associated metabolites represent promising but still evolving therapeutic candidates; their clinical use requires stronger causal evidence, standardized formulations, safety evaluation, and disease-specific validation.  Graphical Abstract: Microbiome-associated metabolites, including short-chain fatty acids, microbial indole derivatives, secondary bile acids, and polyamines, contribute to epithelial homeostasis and regulate immune signaling through pathways such as NF-kappaB, MAPK, JAK-STAT, inflammasome activation, GPCR signaling, and epigenetic remodeling. Therapeutic strategies such as metabolite supplementation, prodrug design, microbiome engineering, and nano-delivery systems may enable targeted anti-inflammatory effects, but their clinical application remains dependent on stronger human evidence and standardized delivery approaches.
SN  - 0360-3997
SN  - 1573-2576
ER  -